FBLG (FibroBiologics) Earnings Power Value (EPV): $-0.26 (As of Mar26)


FBLG FibroBiologics Inc FBLG
13 GF Score
Price $0.80
! 3 Warning Signs
View Full Analysis

What is FibroBiologics Earnings Power Value (EPV)?

FibroBiologics FBLG +7.98% 13 Earnings Power Value (EPV) is $-0.26 as of Mar26. GuruFocus rates FBLG with a GF Score™ of 13/100. The stock has 3 warning signs investors should review.

As of Mar26, FibroBiologics's earnings power value is $-0.26. *

* GuruFocus does not store EPV value into our database if Average Maintenance CAPEX is 0.

Margin of Safety is N/A.

The basic concept of EPV is that one should value a stock based on the current free cash flow of a company and not on future projections which may, or may not, come true. It is arguably a better way to analyze stocks than Discounted Cash Flow analysis that relies on highly speculative growth assumptions many years into the future. Assumption: Current profitability is sustainable.

FibroBiologics  (NAS:FBLG) Earnings Power Value (EPV) Explanation

Assumption: Current profitability is sustainable.

Earnings power value (EPV) uses a very basic equation which assumes no growth, although it does rely on an assumption about the cost of capital as well as the fact that current earnings are sustainable. It also involves several adjustments to clean up the underlying Earnings figures.

Be Aware

Though using today's earnings in calculating Earnings Power Value, GuruFocus is normalizing these earnings to the business cycle. This eliminates the effects on profitability of valuing the firm at different points in the business cycle. This means that we are considering the average earnings over 5 years.

FibroBiologics Earnings Power Value (EPV) Related Terms

FibroBiologics Earnings Power Value (EPV) Historical Data

* Premium members only.

The historical data trend for FibroBiologics's Earnings Power Value (EPV) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

FibroBiologics Earnings Power Value (EPV) Chart

FibroBiologics Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Earnings Power Value (EPV)
0.00 0.00 0.00 0.00 0.00

FibroBiologics Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Earnings Power Value (EPV) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FBLG vs BGMS, AIM, APVO: Earnings Power Value (EPV) Comparison

For the Biotechnology subindustry, FibroBiologics's Earnings Power Value (EPV), along with its competitors' market caps and Earnings Power Value (EPV) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

FibroBiologics Earnings Power Value (EPV) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, FibroBiologics's Earnings Power Value (EPV) distribution charts can be found below:

* The bar in red indicates where FibroBiologics's Earnings Power Value (EPV) falls into.


FBLG
13GF Score
FibroBiologics Inc FBLG
Earnings Power Value (EPV) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

FibroBiologics Earnings Power Value (EPV) Calculation

Earnings Power Value also known as just Earnings Power is a valuation technique popularised by Bruce Greenwald, an authority on value investing at Columbia University. It is arguably a better way to analyze stocks than Discounted Cash Flow analysis that relies on highly speculative growth assumptions many years into the future.

The basic concept of EPV is that one should value a stock based on the current free cash flow of a company and not on future projections which may, or may not, come true. This valuation tool excludes the potential growth that a company may have so that needs to be looked at separately. Since future growth is excluded from the analysis, only the maintenance capital expenditures are subtracted from after-tax EBIT (earnings before interest and taxes) and growth capex is ignored.

What does a Earnings Power Value (EPV) of $-0.26 mean?
FibroBiologics (FBLG) has a Earnings Power Value (EPV) of $-0.26 as of Mar26. Bruce Greenwald's earnings power value focuses on current earnings without factoring in future growth. View historical data on FibroBiologics and its competitors.
Is FibroBiologics' Earnings Power Value (EPV) too high?
FibroBiologics' current Earnings Power Value (EPV) is $-0.26. Overall, FibroBiologics has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does FibroBiologics' Earnings Power Value (EPV) compare to BGMS and AIM?
FibroBiologics' Earnings Power Value (EPV) of $-0.26 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Power Value (EPV) for a Biotechnology company?
A good Earnings Power Value (EPV) depends on the Biotechnology industry context. However, Earnings Power Value (EPV) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Power Value (EPV) mean?
A high Earnings Power Value (EPV) can signal that a stock is expensive relative to its fundamentals. Bruce Greenwald's earnings power value focuses on current earnings without factoring in future growth. View historical data on FibroBiologics and its competitors. FibroBiologics's current Earnings Power Value (EPV) is $-0.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is FibroBiologics stock overvalued right now?
FibroBiologics (FBLG) has a current Earnings Power Value (EPV) of $-0.26. The current Earnings Power Value (EPV) is $-0.26. FibroBiologics' overall GF Score™ is 13/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Power Value (EPV) calculated?
Earnings Power Value (EPV) is calculated from a company's financial statements. For FibroBiologics (FBLG), the current Earnings Power Value (EPV) is $-0.26 as of Mar26. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

FibroBiologics Business Description

Address 455 East Medical Center Boulevard, Suite 300, Houston, TX, USA, 77598
FibroBiologics Inc a clinical-stage biotechnology company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including wound healing, multiple sclerosis, or MS, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications including thymic involution reversal using a thymic organoid. Its product candidates are CYWC628, CYPS317, CYMS101 and CybroCell.
13GF Score

Get the complete analysis for FBLG

Earnings Power Value (EPV) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.80
Price